“Nanorobots de disseny per atacar la malària” (Eng)

IBEC Director and Head of Nanobioengineering, Josep Samitier, and the head of the joint IBEC/CRESIB unit on Nanomalaria, Xavier Fernández-Busquets, both featured in an article in the Catalan daily newspaper Ara this weekend.

Read more…


The article discusses the problem of resistance to the anti-malarial artemisinin, and outlines the attempts being made in the Nanomalaria lab to develop nanoparticles that encapsulate drugs which target only infected cells, that not only recover the activity that resistance has built up against but also exhibit fewer the side effects.

Click here to read the article.